Consumer Health Cancer / Immunology

Oncodesign Services announce access to ImaginAb’s CD8 ImmunoPET™ technology

By using this cutting-edge imaging technology in preclinical studies, Oncodesign Services’ team hopes to gain insights of the predictive effectivenes...

 June 29, 2023 | News

INOVIQ's SubB2M/CA15-3 Breast Cancer Test Shows Excellent Clinical Data

INOVIQ's SubB2M/CA15-3 breast cancer test detects all-stages of breast cancer with excellent accuracy (87%), sensitivity (81%) and specificity (93%) The...

 June 28, 2023 | News

CStone Receives China NMPA Approval for GAVRETO® in First-Line Treatment of RET Fusion-Positive Lung Cancer.

  The approval for the first-line treatment of RET fusion-positive non-small cell lung cancer marks the third indication of GAVRETO in Mainland Chi...

 June 27, 2023 | News

Prenetics and Prof. Dennis Lo Launch US$200m Joint Venture "Insighta" for Multi-Cancer Early Detection

- Insighta is a 50/50 Joint Venture by Prenetics and Professor Dennis Lo. - Insighta is powered by technology developed by the Centre for Novostics w...

 June 26, 2023 | News

Lubrizol Licenses Award-Winning Apisolex™ Excipient to Welton Pharmaceuticals to Develop a Novel Cancer Therapeutic

The Lubrizol Corporation announces the licensing of its novel excipient polymer technology, Apisolex™ excipient, to Welton Pharma (Welton). The licen...

 June 23, 2023 | News

Telix to Present ZIRCON Phase III Kidney Cancer Imaging Data at SNMMI

Further data from Telix's completed pivotal Phase III ZIRCON study of TLX250-CDx (89Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRCC) (Clinic...

 June 23, 2023 | News

SeekIn paves the way for cancer early detection in low- and middle-income countries

The overall accuracy of TOO prediction in the true positives is 66.8%, which may be supportive in the clinical diagnostic workup. OncoSeek® ...

 June 19, 2023 | News

FDA Approves Phase I/II Trial for Leads Biolabs' Anti-MUC16/CD3 Bispecific Antibody in Advanced Solid Tumors.

The study is a multicenter, open-label, dose-escalation and expansion phase Ⅰ/Ⅱ clinical study. The phase Ⅰ part aims to evaluate the safety, to...

 June 19, 2023 | News

FDA Approves Utidelone Injectable (UTD1) Trial for Non-Small Cell Lung Cancer

Designated as BG01-2202, this trial is a multi-national, phase 2/3, open-label, randomized, controlled clinical study of utidelone injectable (UTD1) v...

 June 16, 2023 | News

NCCN Unveils Thyroid Cancer Care Roadmap for Low- and Middle-Income Countries on Global Stage

The National Comprehensive Cancer Network® (NCCN®) is introducing a new global resource to improve thyroid cancer care in low- and middle-inco...

 June 15, 2023 | News

Biostar Pharma Enrolls First Patient for Phase 1 Study of UTD2, World's First Oral Epothilone Anti-Cancer Drug

This study will be conducted at multiple clinical research centers including Sarah Cannon Research Institute (Florida Cancer Specialists & Research Ins...

 June 13, 2023 | News

Lunit's Groundbreaking AI Research Transforms Medical Pathology with Computer Vision, Presented at CVPR 2023

Lunit (KRX:328130.KQ), a leading global provider of AI-powered cancer diagnostic solutions,  announced its participation in the Conference on Computer...

 June 13, 2023 | News

HKSH Medical Group and UCLA Health signed a Development Agreement

HKSH Medical Group (HKSH) and UCLA Health have signed a Development Agreement to strengthen their partnership in knowledge transfer in cancer management. T...

 June 13, 2023 | News

IMBdx Expands Targeted Therapies Agreement after Successful Prostate Cancer Genomic Profiling

The collaboration aims to improve accessibility to targeted therapies for mCRPC patients in international markets outside the US. Traditional tissue biopsi...

 June 09, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close